Precigen, Inc. Reports Q3 2026 Financial Results

What Happened
Precigen, Inc. (PGEN) filed a Form 8‑K on August 4, 2026 (Item 2.02) reporting its financial results for the quarter ended June 30, 2026. The company attached a press release dated August 4, 2026 as Exhibit 99.1 that announces those quarterly results. The filing notes that the press release information “shall not be deemed ‘filed’ for purposes of Section 18” of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.

Key Details

• Filing date: August 4, 2026 (Form 8‑K, Item 2.02).
• Reporting period: Quarter ended June 30, 2026.
• Exhibit attached: Press release dated August 4, 2026 (Exhibit 99.1).
• Interactive data: Cover page interactive XBRL file included (Exhibit 104).

Why It Matters
This 8‑K signals that Precigen has publicly disclosed its latest quarterly earnings and other operating results; those details (revenue, net income/loss, cash position, any guidance) will be in the attached press release and are material for investors assessing the stock. Because the company states the press release is not being “filed” under Section 18, investors should review Exhibit 99.1 directly and watch for the company's periodic filings (e.g., Form 10‑Q) for audited or more complete financial statements and disclosures.